Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy

First-line chemotherapy to combat primary malignant brain cancer is often accompanied by lymphopenic immunologic deficiency. Although counterintuitive, chemotherapy-induced lymphopenia can provide excellent host conditioning that may actually be leveraged to potentiate antitumor immunotherapy. We di...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncoimmunology
Huvudupphovsmän: Sanchez-Perez, Luis, Suryadevara, Carter M, Choi, Bryan D, Reap, Elizabeth A, Sampson, John H
Materialtyp: Artigo
Språk:Inglês
Publicerad: Taylor & Francis 2014
Ämnen:
Author's View
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292586/
https://ncbi.nlm.nih.gov/pubmed/25610727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.944054
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk